These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

742 related articles for article (PubMed ID: 9460746)

  • 1. Glial cell line-derived neurotrophic factor improves intrastriatal graft survival of stored dopaminergic cells.
    Apostolides C; Sanford E; Hong M; Mendez I
    Neuroscience; 1998 Mar; 83(2):363-72. PubMed ID: 9460746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glial cell line-derived neurotrophic factor increases survival, growth and function of intrastriatal fetal nigral dopaminergic grafts.
    Rosenblad C; Martinez-Serrano A; Björklund A
    Neuroscience; 1996 Dec; 75(4):979-85. PubMed ID: 8938733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GDNF triggers fiber outgrowth of fetal ventral mesencephalic grafts from nigra to striatum in 6-OHDA-lesioned rats.
    Wang Y; Tien LT; Lapchak PA; Hoffer BJ
    Cell Tissue Res; 1996 Nov; 286(2):225-33. PubMed ID: 8854891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glial cell line-derived neurotrophic factor improves survival of ventral mesencephalic grafts to the 6-hydroxydopamine lesioned striatum.
    Granholm AC; Mott JL; Bowenkamp K; Eken S; Henry S; Hoffer BJ; Lapchak PA; Palmer MR; van Horne C; Gerhardt GA
    Exp Brain Res; 1997 Aug; 116(1):29-38. PubMed ID: 9305812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glial cell line-derived neurotrophic factor improves survival of dopaminergic neurons in transplants of fetal ventral mesencephalic tissue.
    Yurek DM
    Exp Neurol; 1998 Oct; 153(2):195-202. PubMed ID: 9784279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased survival of dopaminergic neurons in striatal grafts of fetal ventral mesencephalic cells exposed to neurotrophin-3 or glial cell line-derived neurotrophic factor.
    Espejo M; Cutillas B; Arenas TE; Ambrosio S
    Cell Transplant; 2000; 9(1):45-53. PubMed ID: 10784066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth/differentiation factor 5 and glial cell line-derived neurotrophic factor enhance survival and function of dopaminergic grafts in a rat model of Parkinson's disease.
    Sullivan AM; Pohl J; Blunt SB
    Eur J Neurosci; 1998 Dec; 10(12):3681-8. PubMed ID: 9875347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Grafting of nigral tissue hibernated with tirilazad mesylate and glial cell line-derived neurotrophic factor.
    Petersen A; Hansson O; Emgård M; Brundin P
    Cell Transplant; 2000; 9(5):577-84. PubMed ID: 11144955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glial cell line-derived neurotrophic factor attenuates behavioural deficits and regulates nigrostriatal dopaminergic and peptidergic markers in 6-hydroxydopamine-lesioned adult rats: comparison of intraventricular and intranigral delivery.
    Lapchak PA; Miller PJ; Collins F; Jiao S
    Neuroscience; 1997 May; 78(1):61-72. PubMed ID: 9135089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrastriatal glial cell line-derived neurotrophic factor promotes sprouting of spared nigrostriatal dopaminergic afferents and induces recovery of function in a rat model of Parkinson's disease.
    Rosenblad C; Martinez-Serrano A; Björklund A
    Neuroscience; 1998 Jan; 82(1):129-37. PubMed ID: 9483509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glial cell line-derived neurotrophic factor-supplemented hibernation of fetal ventral mesencephalic neurons for transplantation in Parkinson disease: long-term storage.
    Hebb AO; Hebb K; Ramachandran AC; Mendez I
    J Neurosurg; 2003 May; 98(5):1078-83. PubMed ID: 12744369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intranigral ventral mesencephalic grafts and nigrostriatal injections of glial cell line-derived neurotrophic factor restore dopamine release in the striatum of 6-hydroxydopamine-lesioned rats.
    Tang FI; Tien LT; Zhou FC; Hoffer BJ; Wang Y
    Exp Brain Res; 1998 Apr; 119(3):287-96. PubMed ID: 9551829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Astrocytes promote or impair the survival and function of embryonic ventral mesencephalon co-grafts: effects of astrocyte age and expression of recombinant brain-derived neurotrophic factor.
    Krobert K; Lopez-Colberg I; Cunningham LA
    Exp Neurol; 1997 Jun; 145(2 Pt 1):511-23. PubMed ID: 9217087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of human fetal ventral mesencephalic grafts in rats with 6-OHDA lesions of the nigrostriatal pathway.
    Kondoh T; Pundt LL; Low WC
    Neurosci Res; 1995 Jan; 21(3):223-33. PubMed ID: 7753503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of mesencephalic free-floating tissue culture grafts and cell suspension grafts in the 6-hydroxydopamine-lesioned rat.
    Meyer M; Widmer HR; Wagner B; Guzman R; Evtouchenko L; Seiler RW; Spenger C
    Exp Brain Res; 1998 Apr; 119(3):345-55. PubMed ID: 9551835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythropoietin and GDNF enhance ventral mesencephalic fiber outgrowth and capillary proliferation following neural transplantation in a rodent model of Parkinson's disease.
    McLeod M; Hong M; Mukhida K; Sadi D; Ulalia R; Mendez I
    Eur J Neurosci; 2006 Jul; 24(2):361-70. PubMed ID: 16903847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implants of polymer-encapsulated genetically modified cells releasing glial cell line-derived neurotrophic factor improve survival, growth, and function of fetal dopaminergic grafts.
    Sautter J; Tseng JL; Braguglia D; Aebischer P; Spenger C; Seiler RW; Widmer HR; Zurn AD
    Exp Neurol; 1998 Jan; 149(1):230-6. PubMed ID: 9454632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glial cell line-derived neurotrophic factor is expressed in the developing but not adult striatum and stimulates developing dopamine neurons in vivo.
    Strömberg I; Björklund L; Johansson M; Tomac A; Collins F; Olson L; Hoffer B; Humpel C
    Exp Neurol; 1993 Dec; 124(2):401-12. PubMed ID: 7904571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temporal changes in the neurotrophic environment of the denervated striatum as determined by the survival and outgrowth of grafted fetal dopamine neurons.
    Yurek DM; Fletcher-Turner A
    Brain Res; 2002 Mar; 931(2):126-34. PubMed ID: 11897098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implantation of bioactive growth factor-secreting rods enhances fetal dopaminergic graft survival, outgrowth density, and functional recovery in a rat model of Parkinson's disease.
    Törnqvist N; Björklund L; Almqvist P; Wahlberg L; Strömberg I
    Exp Neurol; 2000 Jul; 164(1):130-8. PubMed ID: 10877923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.